Fluoroquinolone antibiotics are associated with an increased risk of blood glucose swings in diabetic patients, researchers reported.
In a large cohort study, the fluoroquinolones were linked to a heightened risk of both hypo- and hyperglycemia, compared with other antibiotic classes, according to Mei-Shu Lai, MD, PhD, and colleagues at the National Taiwan University in Taipei.
The risks were low -- observed in fewer than one in 100 patients studied -- but clinicians should be cautious when treating diabetic patients with fluoroquinolones, Lai and colleagues reported online in Clinical Infectious Diseases.
"Other antibiotics should be considered if dysglycemia is a concern," Lai and colleagues argued.
Read the full story here: http://bit.ly/1cFRT4B
Source: Med Page Today